Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/7843
Title: | Characterizing the West Nile Virus’s polyprotein from nucleotide sequence to protein structure - Computational tools |
Authors: | Praveen, Mallari |
Keywords: | Antiviral drugs Drug design Flaviviridae Genome Physicochemical West Nile Virus |
Issue Date: | 2024 |
Publisher: | Journal of Taibah University Medical Sciences |
Series/Report no.: | Original Article;338-350 |
Abstract: | Objectives: West Nile virus (WNV) belongs to the Flaviviridae family and causes West Nile fever. The mechanism of transmission involves the culex mosquito species. Infected individuals are primarily asymptomatic, and few exhibit common symptoms. Moreover, 10 % of neuronal infection caused by this virus cause death. The proteins encoded by these genes had been uncharacterized, although understanding their function and structure is important for formulating antiviral drugs. Methods: Herein, we used in silico approaches, including various bioinformatic tools and databases, to analyse the proteins from the WNV polyprotein individually. The characterization included GC content, physicochemical properties, conserved domains, soluble and transmembrane regions, signal localization, protein disorder, and secondary structure features and their respective 3D protein structures. Results: Among 11 proteins, eight had >50 % GC content, eight proteins had basic pI values, three proteins were unstable under in vitro conditions, four were thermostable according to >100 AI values and some had negative GRAVY values in physicochemical analyses. All protein-conserved domains were shared among Flaviviridae family members. Five proteins were soluble and lacked transmembrane regions. Two proteins had signals for localization in the host endoplasmic reticulum. Non-structural (NS) 2A showed low protein disorder. The secondary structural features and tertiary structure models provide a valuable biochemical resource for designing selective substrates and synthetic inhibitors. Conclusions: WNV proteins NS2A, NS2B, PM, NS3 and NS5 can be used as drug targets for the pharmacological design of lead antiviral compounds. |
URI: | http://localhost:8080/xmlui/handle/123456789/7843 |
ISSN: | 1658-3612 |
Appears in Collections: | Vol 19 No 2 (2024) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
338-350.pdf | 4.43 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.